BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12
1900 results:

  • 1. Management of Advanced Medullary Thyroid Carcinoma: Current Systemic Therapy Options.
    Jara MA
    Crit Rev Oncog; 2024; 29(3):83-90. PubMed ID: 38683155
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
    Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
    Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Accelerated men2a in homozygous ret carriers in the context of consanguinity.
    Machens A; Dralle H
    Eur J Endocrinol; 2024 Mar; 190(3):K43-K46. PubMed ID: 38465999
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular classification and tumor microenvironment characteristics in pheochromocytomas.
    Qin S; Xu Y; Yu S; Han W; Fan S; Ai W; Zhang K; Wang Y; Zhou X; Shen Q; Gong K; Sun L; Zhang Z
    Elife; 2024 Feb; 12():. PubMed ID: 38407266
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The role of prophylactic parathyroidectomy during thyroidectomy for MTC in patients with men2a syndrome.
    Kavazis C; Romanidis K; Pitiakoudis M; Kesisoglou I; Laskou S; Sapalidis K
    Folia Med (Plovdiv); 2023 Oct; 65(5):720-727. PubMed ID: 38351753
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ret kinase inhibitors for the treatment of ret-altered thyroid cancers: Current knowledge and future directions.
    Hamidi S; Hu MI
    Ann Endocrinol (Paris); 2024 Apr; 85(2):118-126. PubMed ID: 38342224
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Updates on the genetics of multiple endocrine neoplasia.
    Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
    Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Thyroid Cancer: A Review.
    Boucai L; Zafereo M; Cabanillas ME
    JAMA; 2024 Feb; 331(5):425-435. PubMed ID: 38319329
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Intestinal ganglioneuromatosis as an early extra-endocrine manifestation of type 2B multiple endocrine neoplasia].
    Averianova JV; Kalinchenko NY; Brovin DN; Petryaykina EE; Tiulpakov AN
    Probl Endokrinol (Mosk); 2023 Jun; 69(6):109-112. PubMed ID: 38312000
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [A Case Report of Multiple Endocrine Neoplasia Type 2A(men2a)Diagnosed with Medullary Thyroid Carcinoma].
    Morikawa N; Yoshitomi S; Shimabara M; Tatara N; Hara K; Ikeda E; Tsuji H
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1780-1782. PubMed ID: 38303205
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Extent of Surgery for Medullary Thyroid Cancer and Prevalence of Occult Contralateral Foci.
    Mao YV; Hughes EG; Steinmetz D; Troob S; Kim J; Tseng CH; Fishbein GA; Sajed DP; Livhits MJ; Yeh MW; Lee D; Angell TE; Wu JX
    JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):209-214. PubMed ID: 38270925
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Efficacy and safety of pralsetinib in Chinese advanced ret-mutant medullary thyroid cancer patients.
    Zheng X; Fang M; Fan Y; Sun Y; Sun M; Yang A; Zhang B; Liu Q; Liu H; Zhou X; Huang T; Qin J; Wang Z; Qin M; Shen Z; Yao S; Yang J; Wang Y; Gao M
    Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38261313
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. An audit of medullary thyroid carcinoma from a tertiary care hospital in northwest India.
    Chakraborty AM; Rai A; Pal R; Mukherjee S; Dahiya D; Kumar R; Saikia UN; Panda NK; Bhadada SK; Dutta P
    Front Endocrinol (Lausanne); 2023; 14():1226348. PubMed ID: 38260132
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Precision medicine in endocrinology exemplified by medullary thyroid cancer].
    Brandenburg T; Machlah YM; Führer D
    Inn Med (Heidelb); 2024 Mar; 65(3):202-210. PubMed ID: 38231404
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
    Pallocca M; Molineris I; Berrino E; Marcozzi B; Betti M; Levati L; D'Atri S; Menin C; Madonna G; Ghiorzo P; Bulgarelli J; Ferraresi V; Venesio T; Rodolfo M; Rivoltini L; Lanfrancone L; Ascierto PA; Mazzarella L; Pelicci PG; De Maria R; Ciliberto G; Medico E; Russo G
    J Transl Med; 2024 Jan; 22(1):29. PubMed ID: 38184610
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review.
    Fallahi P; Patrizio A; Stoppini G; Elia G; Ragusa F; Paparo SR; Balestri E; Mazzi V; Botrini C; Varricchi G; Ulisse S; Ghionzoli M; Antonelli A; Ferrari SM
    Curr Oncol; 2023 Nov; 30(12):10237-10248. PubMed ID: 38132379
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Patterns of Treatment Failure After Selective Rearranged During Transfection (ret) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma.
    Hadoux J; Al Ghuzlan A; Lamartina L; Bani MA; Moog S; Attard M; Scoazec JY; Hartl D; Aldea M; Friboulet L; Jules-Clement G; Italiano A; Besse B; Lacroix L; Baudin E
    JCO Precis Oncol; 2023 Sep; 7():e2300053. PubMed ID: 38127829
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary Thyroid Cancer.
    Gild ML; Kumar S; Fuchs TL; Glover A; Sidhu S; Sywak M; Tsang V; Gill AJ; Robinson BG; Schembri G; Clifton-Bligh RJ; Hoang J
    Endocr Pract; 2024 Mar; 30(3):218-224. PubMed ID: 38103829
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma.
    Censi S; Galuppini F; Clausi C; Battheu F; Manso J; Piva I; Corvaglia S; Pedron MC; Mondin A; Iacobone M; Torresan F; Merante Boschin I; Bertazza L; Barollo S; Pennelli G; Mian C
    Thyroid; 2024 Feb; 34(2):177-185. PubMed ID: 38047536
    [No Abstract]    [Full Text] [Related]  

  • 20. Clinical characteristics of a large familial cohort with Medullary thyroid cancer and germline Cys618Arg
    Rosenblum RC; Hirsch D; Grozinsky-Glasberg S; Benbassat C; Yoel U; Ishay A; Zolotov S; Bachar G; Banne E; Levy S; Twito O
    Front Endocrinol (Lausanne); 2023; 14():1268193. PubMed ID: 38027168
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 95.